T. Rowe Price Associates
BIVV

T. Rowe Price Associates’s Bioverativ Inc. Common Stock BIVV Stock Holding History

T. Rowe Price Associates’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-5,087,776
Closed -$274M – 2593
2017
Q4 		$274M Buy
5,087,776
+1,300,396
+34% +$70.1M 0.04% 388
2017
Q3 		$216M Buy
3,787,380
+1,294,586
+52% +$73.9M 0.04% 436
2017
Q2 		$150M Buy
2,492,794
+1,186,806
+91% +$71.4M 0.03% 502
2017
Q1 		$71.1M Buy
+1,305,988
New +$71.1M 0.01% 692